Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 1st Quarter 2016 Financial Results on August 11, 2015
August 06, 2015 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
June 16, 2015 10:33 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 16, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the issuance of U.S. Patent No. 9,056,054 entitled...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2015
June 15, 2015 16:58 ET
|
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals Reports Nine Percent Revenue Growth
Webcast and Conference Call Scheduled for Tuesday, June 16 at 11:00 AM EDT
NORTHVALE, N.J., June 15, 2015 (GLOBE NEWSWIRE) -- Elite...
CORRECTION -- Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Year End 2015 Financial Results on June 16, 2015
June 11, 2015 18:24 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 11, 2015 (GLOBE NEWSWIRE) -- In the press release issued earlier today by Elite Pharmaceuticals, Inc. (OTCQB:ELTP) with the same headline, please note that the conference call...
Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Year End 2015 Financial Results on June 16, 2015
June 11, 2015 16:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 11, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200
June 09, 2015 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 9, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing...
Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules
January 15, 2015 10:46 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg...
Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation
December 16, 2014 08:38 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the continued expansion of Elite's intellectual property...
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse-Deterrent Oxycodone Product ELI-201
December 03, 2014 09:55 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today successful results from a pivotal bioequivalence (BE) study for...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015
November 18, 2014 18:24 ET
|
Elite Pharmaceuticals, Inc.
Revenues increase by 8%
Conference Call Scheduled for Wednesday, November 19 at 11:00 AM EST
NORTHVALE, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the...